Anatomical and biochemical investigation of primary brain tumours

[1]  Scott W. Atlas,et al.  Magnetic Resonance Imaging of the Brain and Spine , 1991 .

[2]  P. Black,et al.  Cellular-telephone use and brain tumors. , 2001, The New England journal of medicine.

[3]  M. Deckert,et al.  Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment , 2000, Journal of the Neurological Sciences.

[4]  D. Scadden.  Epstein-Barr virus, the CNS, and AIDS-related lymphomas: as close as flame to smoke. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Blankenstein,et al.  Occurrence, regulation, and significance of progesterone receptors in human meningioma , 2000, Steroids.

[6]  M Teräs,et al.  Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. , 2000, International journal of radiation oncology, biology, physics.

[7]  E. Holly,et al.  Childhood brain tumours and exposure to animals and farm life: a review. , 2000, Paediatric and perinatal epidemiology.

[8]  F. Chapon,et al.  Non-invasive grading of oligodendrogliomas: correlations between in vivo metabolic pattern and histopathology , 2000, European Journal of Nuclear Medicine.

[9]  M. Weckesser,et al.  Evaluation of the Extension of Cerebral Gliomas by Scintigraphy , 2000, Strahlentherapie und Onkologie.

[10]  B. Harding,et al.  Management of Choroid Plexus Tumours in Children: 20 Years Experience at a Single Neurosurgical Centre , 2000, Pediatric Neurosurgery.

[11]  M Tanabe,et al.  Visualization of the motor activation area using SPECT in neurosurgical patients with lesions near the central sulcus. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Reiman,et al.  Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. , 2000, Journal of neurosurgery.

[13]  M Schwaiger,et al.  Reproducibility of metabolic measurements in malignant tumors using FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P. Ricci.  Imaging of adult brain tumors. , 1999, Neuroimaging clinics of North America.

[15]  S. Nelson,et al.  Imaging of brain tumors after therapy. , 1999, Neuroimaging clinics of North America.

[16]  J. Smirniotopoulos.  The new WHO classification of brain tumors. , 1999, Neuroimaging clinics of North America.

[17]  A. Alavi,et al.  Can the standardized uptake value characterize primary brain tumors on FDG-PET? , 1999, European Journal of Nuclear Medicine.

[18]  P. Black,et al.  Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. , 1999, Neurosurgery.

[19]  N. Gupta,et al.  FDG-PET in the staging work-up of patients with suspected intracranial metastatic tumors. , 1999, Annals of surgery.

[20]  N Tonami,et al.  201Tl SPET in the differential diagnosis of brain tumours. , 1999, Nuclear medicine communications.

[21]  T. Dóczi,et al.  Sporadic p53 Mutations and Absence of Ras Mutations in Glioblastomas , 1999, Acta Neurochirurgica.

[22]  K. Herholz,et al.  Positron emission tomography in a case of intracranial hemangiopericytoma. , 1999, Journal of computer assisted tomography.

[23]  M Takahashi,et al.  Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.

[24]  F. Speleman,et al.  Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein , 1999, European Journal of Nuclear Medicine.

[25]  S. Schoenberg,et al.  Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging. , 1999, Radiology.

[26]  J. A. Cameron,et al.  Presurgical evaluation of the motor hand area with functional MR imaging in patients with tumors and dysplastic lesions. , 1999, Radiology.

[27]  F. Barral,et al.  Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy , 1998, European Journal of Nuclear Medicine.

[28]  M. Sant,et al.  Survival rates for primary malignant brain tumours in Europe. EUROCARE Working Group. , 1998, European journal of cancer.

[29]  B. Scheithauer,et al.  The results of radiotherapy for ependymomas: the Mayo Clinic experience. , 1998, International journal of radiation oncology, biology, physics.

[30]  C. Muirhead,et al.  Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy , 1998, International journal of cancer.

[31]  G. Csécsei,et al.  Detection of elevated oncogene expressions in brain tumours and their macroscopically healthy surrounding tissues. , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[32]  M. Sasaki,et al.  A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours , 1998, European Journal of Nuclear Medicine.

[33]  I. Wilkinson,et al.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. , 1998, Sexually transmitted infections.

[34]  J. Machac,et al.  Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  G. Filippini,et al.  Incidence and survival of childhood CNS tumours in the Region of Lombardy, Italy. , 1998, Brain : a journal of neurology.

[36]  E. Voth,et al.  Somatostatin receptor imaging in intracranial tumours , 1998, European Journal of Nuclear Medicine.

[37]  A. Soricelli,et al.  Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  S. El-Saden,et al.  Cerebral gangliogliomas: preoperative grading using FDG-PET and 201Tl-SPECT. , 1998, AJNR. American journal of neuroradiology.

[39]  M. McBride,et al.  Childhood cancer and environmental contaminants. , 1998, Canadian journal of public health = Revue canadienne de sante publique.

[40]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  J. Unterrainer,et al.  Clinical relevance of 201Tl-chloride SPET in the differential diagnosis of brain tumours. , 1998, Nuclear medicine communications.

[42]  S. Jinnouchi,et al.  Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET? , 1998, European Journal of Nuclear Medicine.

[43]  C P Das,et al.  Neurological complications of HIV infection. , 1998, Neurology India.

[44]  Martin Kk,et al.  Nm23: an invasion suppressor gene in CNS tumours? , 1998 .

[45]  N. Lundbom,et al.  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997, Journal of Neurosurgery.

[46]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  J. Kuratsu,et al.  Epidemiological study of primary intracranial tumours in elderly people , 1997, Journal of neurology, neurosurgery, and psychiatry.

[48]  H. Herzog,et al.  3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  T. Hölzer,et al.  The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine. , 1997, Neurosurgery.

[50]  N. Shinoura,et al.  Brain tumors: detection with C-11 choline PET. , 1997, Radiology.

[51]  L. Deecke,et al.  Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  M. Hartmann,et al.  MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. , 1996, AJNR. American journal of neuroradiology.

[53]  D. Parkin,et al.  Geographic and ethnic variations in the incidence of childhood cancer. , 1996, British medical bulletin.

[54]  T. Araki,et al.  Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  S. Goldman,et al.  Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. , 1996, Neurosurgery.

[56]  D Fewer,et al.  Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy , 1996, Journal of magnetic resonance imaging : JMRI.

[57]  C. Sarkar,et al.  c‐myc oncogene expression and cell proliferation in mixed oligo‐astrocytoma , 1996 .

[58]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[59]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[60]  I. Kanno,et al.  Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. , 1996, AJNR. American journal of neuroradiology.

[61]  C. Counsell,et al.  The incidence of cerebral glioma in the working population: a forgotten cancer? , 1996, British Journal of Cancer.

[62]  C. Stiller,et al.  Childhood cancer in Britain: the National Registry of Childhood Tumours and incidence rates 1978-1987. , 1995, European journal of cancer.

[63]  B. Scheithauer,et al.  Histopathology, classification, and grading of gliomas , 1995, Glia.

[64]  R. Miller,et al.  Radionuclide brain imaging in acquired immunodeficiency syndrome (AIDS). , 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[65]  M. Marzola,et al.  SPET imaging of intracranial tumours with 99Tcm-sestamibi , 1995, Nuclear medicine communications.

[66]  A. Luxen,et al.  Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. , 1995, Journal of neurosurgery.

[67]  R. Iwata,et al.  Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[68]  P Okunieff,et al.  Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. , 1994, International journal of radiation oncology, biology, physics.

[69]  D. Louis,et al.  Genetic basis of neurological tumours. , 1994, Bailliere's clinical neurology.

[70]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[71]  G. di Chiro,et al.  Neuroimaging of juvenile pilocytic astrocytomas: an enigma. , 1993, Radiology.

[72]  R. Coleman,et al.  Serial FDG‐PET Studies in the Prediction of Survival in Patients with Primary Brain Tumors , 1993, Journal of computer assisted tomography.

[73]  Y. Yonekura,et al.  Glucose consumption in recurrent gliomas. , 1993, Neurosurgery.

[74]  S. Treves,et al.  Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[75]  R. Coleman,et al.  FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[76]  R. Kramer,et al.  Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. , 1993, Cancer research.

[77]  M. Bergström,et al.  Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and [11C]-L-deprenyl. , 1992, Neurosurgery.

[78]  D. Podoloff,et al.  Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.

[79]  R. Coleman,et al.  FDG-PET in the selection of brain lesions for biopsy. , 1991, Journal of computer assisted tomography.

[80]  C Crouzel,et al.  PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[81]  P M Black,et al.  Brain tumors. Part 1. , 1991, The New England journal of medicine.

[82]  F. Shishido,et al.  Clinical Value of Pet with 18F-Fluorodeoxyglucose and L-Methyl-11C-Methionine for Diagnosis of Recurrent Brain Tumor and Radiation Injury , 1991, Acta radiologica.

[83]  A. Friedman,et al.  Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography , 1991, Annals of neurology.

[84]  J. Kronauge,et al.  Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.

[85]  M E Moseley,et al.  Diffusion-weighted MR imaging of the brain: value of differentiating between extraaxial cysts and epidermoid tumors. , 1990, AJR. American journal of roentgenology.

[86]  J C Mazziotta,et al.  Thallium-201 SPECT imaging of brain tumors: methods and results. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[87]  H. Bloom,et al.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). , 1990, European journal of cancer.

[88]  G. L. Watkins,et al.  PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site , 1989, Annals of neurology.

[89]  T Ido,et al.  Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[90]  Abass Alavi,et al.  Positron emission tomography in patients with glioma a predictor of prognosis , 1988, Cancer.

[91]  R. Brooks,et al.  PET quantitation: blessing and curse. , 1988, Journal of Nuclear Medicine.

[92]  M. Bergström,et al.  Positron Emission Tomography with 11C-Methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies , 1987, Acta radiologica.

[93]  G. Krol,et al.  Hemorrhagic neoplasms: MR mimics of occult vascular malformations. , 1987, AJR. American journal of roentgenology.

[94]  Alan C. Evans,et al.  Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[95]  S. Atlas,et al.  Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. , 1987, Radiology.

[96]  H von Holst,et al.  PET Study of Methionine Accumulation in Glioma and Normal Brain Tissue: Competition with Branched Chain Amino Acids , 1987, Journal of computer assisted tomography.

[97]  J. Fraumeni,et al.  Occupational risks for intracranial gliomas in Sweden. , 1987, Journal of the National Cancer Institute.

[98]  F. Shishido,et al.  Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. , 1986, Neurological research.

[99]  R. Frackowiak,et al.  Glucose Transport across the Blood—Brain Barrier in Normal Human Subjects and Patients with Cerebral Tumours Studied Using [11C]3-O-Methyl-D-Glucose and Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  H Lundqvist,et al.  Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone. , 1986, Journal of computer assisted tomography.

[101]  M. Bergström,et al.  Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors. , 1985, Journal of computer assisted tomography.

[102]  R. Gatenby,et al.  Oxygen tension in human tumors: in vivo mapping using CT-guided probes. , 1985, Radiology.

[103]  G Di Chiro,et al.  Prediction of survival in glioma patients by means of positron emission tomography. , 1985, Journal of neurosurgery.

[104]  T Jones,et al.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas , 1983, Annals of neurology.

[105]  R A Brooks,et al.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography , 1982, Neurology.

[106]  F. Berrino,et al.  Gliomas and occupational exposure to carcinogens: case-control study. , 1982, American journal of epidemiology.

[107]  Sage Mr.  Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. , 1982, AJR. American journal of roentgenology.

[108]  M Hatanaka,et al.  Transport of sugars in tumor cell membranes. , 1974, Biochimica et biophysica acta.

[109]  K. Isselbacher.  Sugar and amino acid transport by cells in culture--differences between normal and malignant cells. , 1972, The New England journal of medicine.

[110]  R. Ambinder,et al.  Primary central nervous system lymphoma. , 2001, Cancer treatment and research.

[111]  W. Biernat.  2000 World Health Organization classification of tumors of the nervous system. , 2000, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[112]  E. Krenning,et al.  Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas , 1999, European Journal of Nuclear Medicine.

[113]  K. Sartor,et al.  MR imaging of the brain: tumors , 1999, European Radiology.

[114]  Susan M. Chang,et al.  18‐fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma , 1997, Cancer.

[115]  J. Hatazawa,et al.  Early delineation of cerebral glioma using amino acid positron tracers. , 1997, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[116]  W. Cavenee,et al.  Genetics and malignant progression of human brain tumours. , 1995, Cancer surveys.

[117]  C. Intenzo,et al.  Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma. , 1994, Clinical nuclear medicine.

[118]  C Van Ongeval,et al.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.

[119]  G. di Chiro,et al.  Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. , 1989, Neurosurgery.

[120]  A. Bockisch,et al.  Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT , 1989 .

[121]  G. di Chiro,et al.  Brain imaging of glucose utilization in cerebral tumors. , 1988, American journal of physiologic imaging.

[122]  H. Atkins,et al.  Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[123]  M. Bergström,et al.  Tumour delineation with magnetic resonance imaging in gliomas. A comparison with positron emission tomography and computed tomography. , 1986, Acta radiologica. Supplementum.

[124]  A. Moss.  Occupational exposure and brain tumors. , 1985, Journal of toxicology and environmental health.

[125]  R Fankhauser,et al.  Tumours of the nervous system. , 1974, Bulletin of the World Health Organization.

[126]  F. Barral,et al.  Technetium-99 m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy , 2022 .